137 related articles for article (PubMed ID: 17716630)
21. Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
Broccardo M; Scaccianoce S; Del Bianco P; Agostini S; Petrella C; Improta G
Neurogastroenterol Motil; 2005 Dec; 17(6):871-7. PubMed ID: 16336503
[TBL] [Abstract][Full Text] [Related]
22. Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress.
Adamec R; Muir C; Grimes M; Pearcey K
Behav Brain Res; 2007 May; 179(2):192-207. PubMed ID: 17335916
[TBL] [Abstract][Full Text] [Related]
23. Ontogeny of corticotropin-releasing factor effects on locomotion and foraging in the Western spadefoot toad (Spea hammondii).
Crespi EJ; Denver RJ
Horm Behav; 2004 Nov; 46(4):399-410. PubMed ID: 15465525
[TBL] [Abstract][Full Text] [Related]
24. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal.
Papaleo F; Kitchener P; Contarino A
Neuron; 2007 Feb; 53(4):577-89. PubMed ID: 17296558
[TBL] [Abstract][Full Text] [Related]
25. The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.
Sutherland JE; Burian LC; Covault J; Conti LH
Pharmacol Biochem Behav; 2010 Dec; 97(2):227-38. PubMed ID: 20709096
[TBL] [Abstract][Full Text] [Related]
26. Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain.
Conti LH; Costill JE; Flynn S; Tayler JE
Behav Neurosci; 2005 Aug; 119(4):1052-60. PubMed ID: 16187833
[TBL] [Abstract][Full Text] [Related]
27. The chakragati mouse shows deficits in prepulse inhibition of acoustic startle and latent inhibition.
Verma V; Tan CH; Ong WY; Grigoryan GA; Jones CA; Stolzberg D; Salvi R; Gross KW; Ratty AK; Dawe GS
Neurosci Res; 2008 Mar; 60(3):281-8. PubMed ID: 18164085
[TBL] [Abstract][Full Text] [Related]
28. [Analgesic effect of corticotropin releasing factor (CRF) on somatic pain sensitivity: participation of glucocorticoid and CRF-2 receptors].
Iarushkina NI; Bagaeva TR; Filaretova LP
Ross Fiziol Zh Im I M Sechenova; 2008 Oct; 94(10):1118-25. PubMed ID: 19065825
[TBL] [Abstract][Full Text] [Related]
29. Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice.
Tovote P; Meyer M; Ronnenberg A; Ogren SO; Spiess J; Stiedl O
Neuroscience; 2005; 134(4):1113-22. PubMed ID: 16039799
[TBL] [Abstract][Full Text] [Related]
30. Normal prepulse inhibition and habituation of acoustic startle response in suicidal depressive patients without psychotic symptoms.
Quednow BB; Westheide J; Kühn KU; Werner P; Maier W; Hawellek B; Wagner M
J Affect Disord; 2006 Jun; 92(2-3):299-303. PubMed ID: 16503358
[TBL] [Abstract][Full Text] [Related]
31. Transient forebrain over-expression of CRF induces plasma corticosterone and mild behavioural changes in adult conditional CRF transgenic mice.
Vicentini E; Arban R; Angelici O; Maraia G; Perico M; Mugnaini M; Ugolini A; Large C; Domenici E; Gerrard P; Bortner D; Mansuy IM; Mangiarini L; Merlo-Pich E
Pharmacol Biochem Behav; 2009 Jul; 93(1):17-24. PubMed ID: 19358863
[TBL] [Abstract][Full Text] [Related]
32. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
[TBL] [Abstract][Full Text] [Related]
33. Metyrapone and mifepristone reverse recognition memory loss induced by spontaneous morphine withdrawal in mice.
Mesripour A; Hajhashemi V; Rabbani M
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):377-81. PubMed ID: 18341515
[TBL] [Abstract][Full Text] [Related]
34. Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor.
Conti LH; Berridge CW; Tayler JE
Pharmacol Biochem Behav; 2006 Sep; 85(1):261-72. PubMed ID: 16996121
[TBL] [Abstract][Full Text] [Related]
35. Analgesic actions of corticotropin-releasing factor (CRF) on somatic pain sensitivity: involvement of glucocorticoid and CRF-2 receptors.
Yarushkina NI; Bagaeva TR; Filaretova LP
Neurosci Behav Physiol; 2009 Nov; 39(9):819-23. PubMed ID: 19830568
[TBL] [Abstract][Full Text] [Related]
36. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis.
Mayer JL; Klumpers L; Maslam S; de Kloet ER; Joëls M; Lucassen PJ
J Neuroendocrinol; 2006 Aug; 18(8):629-31. PubMed ID: 16867184
[TBL] [Abstract][Full Text] [Related]
37. Primary and secondary neural networks of auditory prepulse inhibition: a functional magnetic resonance imaging study of sensorimotor gating of the human acoustic startle response.
Campbell LE; Hughes M; Budd TW; Cooper G; Fulham WR; Karayanidis F; Hanlon MC; Stojanov W; Johnston P; Case V; Schall U
Eur J Neurosci; 2007 Oct; 26(8):2327-33. PubMed ID: 17908169
[TBL] [Abstract][Full Text] [Related]
38. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating.
Vinkers CH; Risbrough VB; Geyer MA; Caldwell S; Low MJ; Hauger RL
Pharmacol Biochem Behav; 2007 Mar; 86(3):550-8. PubMed ID: 17324452
[TBL] [Abstract][Full Text] [Related]
39. Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.
Sutherland JE; Conti LH
Neuropharmacology; 2011 Mar; 60(4):561-71. PubMed ID: 21185316
[TBL] [Abstract][Full Text] [Related]
40. Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide.
Curtin NM; Boyle NT; Mills KH; Connor TJ
Brain Behav Immun; 2009 May; 23(4):535-47. PubMed ID: 19217938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
